BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced b...

June 07, 2023 | News

Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch

Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...

June 07, 2023 | News

Lunit & Capio S:t Göran Hospital Collaborate for AI-Powered Mammography Analysis

Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply and license agree...

June 06, 2023 | News

Gencurix Announces Clinical Research Results At ASCO 2023

Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly compa...

June 06, 2023 | News

Seegene Obtains IVDR Certification for 30 Diagnostic Assays

Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements New regulation...

June 02, 2023 | News

GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...

June 02, 2023 | News

Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers

87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...

June 01, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

May 31, 2023 | News

HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Pharma Collaborate on Parkinson's Therapy

HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...

May 26, 2023 | News

Lunit's AI-Biomarker Platform Shows Predictive Value at ASCO 2023

Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Soc...

May 26, 2023 | News

Daewoong Pharmaceutical Reveals Bersiporocin's Antifibrotic Mechanism

Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporo...

May 26, 2023 | News

Avixgen accelerates the progress on new drug pipeline development

DxVx has released development updates on the pipelines of its recently acquired company, Avixgen. DxVx acquired about 63% stake of Avixgen, which is a new ...

May 25, 2023 | News

PharmAbcine's Novel Antibody Approved for Clinical Trial in nAMD

The Phase I clinical trial is an open-label, multi-center, single and multiple ascending-dose study to assess safety, tolerability, MTD (maximum tolerated ...

May 24, 2023 | News

SK Bioscience Proposes Vaccine Access Solution at World Economic Forum's Collaborative

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company's CE...

May 24, 2023 | News

Stay Connected